Lactate production is a consequence of cardiac surgery and cardiopulmonary bypass. Patients with elevated lactate levels have increased 30-day mortality. This video addresses the etiology of elevated lactate and aggressive treatment to ensure the best postoperative outcome.

Presenters:
Shahnur Ahmed 
Wayne State University 

Frank A. Baciewicz Jr., MD
Wayne State University 

Duration
8 min.

Vasoplegic shock after cardiopulmonary bypass is characterized by refractory hypotension and high cardiac output with systemic vasodilatation. It also is associated with increased mortality. In this video, the latest strategies to prevent, mitigate, and treat this common problem are discussed.

Presenter:
Subhasis Chatterjee, MD
Baylor College of Medicine

Contributor:
Joseph Rabin, MD
University of Maryland Medical Center

Duration
9 min.
Importance of considering delirium as a medical emergency in the postoperative cardiac surgery patient.
Duration
9 min.

Robotics is being called the “fourth industrial revolution.” For some cardiothoracic surgeons, robotics means smaller, faster, and easier, resulting in patients getting out of the hospital sooner, having less pain, and returning to function faster. For others, the jury is still out on whether or not robotics will add long-term value, especially if surgeons face potential carpal tunnel injuries, back pain, and cervical stenosis. David T. Cooke, MD, moderates a panel discussion with Robert E. Merritt, MD, Lana Y. Schumacher, MD, Melanie A. Edwards, MD, and Inderpal S. Sarkaria, MD.

They discuss the learning curve for robotic surgery, the complexity of procedures that can be performed robotically, a team approach to robotic surgery, getting hands-on experience, and future improvements to robotic technology.
20 min.

For cardiothoracic surgeons who are hoping to advance in their careers, it’s often difficult to balance clinical work with the scholarly activities that are necessary for promotion in a modern academic medicine environment. Ourania A. Preventza, MD, and colleagues including Himanshu J. Patel, MD, Elaine E. Tseng, MD, and Sunil Singhal, MD, provide insight on the processes required and tips to help young surgeons successfully get to the next step.

Cardiothoracic surgeons are studying the use of artificial intelligence (AI) and machine learning (ML) to improve risk prediction in the hopes that patient outcomes also will improve. Arman Kilic, MD, and Ara A. Vaporciyan, MD, along with medical student Brian Ayers, discuss what AI and ML mean, how it can uncover previously unknown relationships in medical data, and how it can be used to assist the surgeon in the operating room.

Panelists provide insight on the processes required and tips to help young surgeons successfully get to the next step.
22 min.

More than 100,000 people in the United States currently are waiting for a lifesaving organ transplant, including 5,000 people on the transplant list for a heart and/or lungs, according to the United Network for Organ Sharing. Although some will die before they receive a transplant, surgeons and research teams are making great strides in expanding the pool of viable organs. Zachary N. Kon, MD, moderates a discussion with Ashish S. Shah, MD, Matthew G.

Duration
23 min.
Cardiothoracic surgeons are studying the use of artificial intelligence (AI) and machine learning (ML) to improve risk prediction in the hopes that patient outcomes also will improve.
15 min.

Understanding a patient’s frailty index is an important part of assessing the risks and benefits of a surgical procedure for a cardiothoracic surgery patient. Frailty sometimes is measured by a patient’s grip strength, weight, and walking test results, but standards for evaluating and treating frailty before surgery do not exist.

Cardiovascular disease is the #1 killer of people around the world, with approximately 18 million deaths annually, according to the World Health Organization. Treatment options for heart disease include lifestyle changes, stenting, and surgery. But which option is best and for which patients? Thomas E. MacGillivray, MD (Houston Methodist Hospital, Houston, TX), moderates a panel discussion with Jennifer S. Lawton, MD (Johns Hopkins Medicine, Baltimore, MD), John D.